- Inhibitors
- Antibodies
- Compound Libraries
- New Products
- Contact Us
Synonyms: Ado-Trastuzumab emtansine
Trastuzumab Emtansine(T-DM1,Ado-Trastuzumab emtansine) is an antibody-drug conjugate (ADC) that incorporates the HER2-targeted antitumor properties of trastuzumab with the cytotoxic activity of the microtubule-inhibitory agent DM1.Trastuzumab emtansine has a molecular weight of 145kDa.This product is supplied as 10mg/ml PBS solution.
CAS No. 1018448-65-1
| Name | Citation | HER2 | Others |
|---|---|---|---|
| Canertinib (CI-1033) | 48 | EGFR | |
| CP-724714 | 109 | ||
| Sapitinib (AZD8931) | 50 | ErbB3,EGFR | |
| CUDC-101 | 23 | EGFR,HDAC,HDAC1 | |
| Mubritinib (TAK 165) | 40 | ||
| AEE788 (NVP-AEE788) | 13 | EGFR,c-Abl,FLT1 | |
| AC480 (BMS-599626) | 10 | HER1,HER4 | |
| TAK-285 | 4 | EGFR/HER1,HER4,MEK1 | |
| Tyrphostin AG 879 | 3 | Trk | |
| Tuxobertinib (BDTX-189) | 2 | EGFR,RIPK2,BLK | |
| Epertinib hydrochloride | 0 | EGFR,HER4 | |
| TAS0728 | 1 | ||
| Tyrphostin AG-528 | 0 | EGFR | |
| SU5204 | 1 | VEGFR-2 | |
| Pyrotinib dimaleate | 4 | EGFR | |
| Poziotinib (HM781-36B) | 35 | HER1,HER4 | |
| [[${prodTargetCompareList.name}]] | 1 | ||
| [[${prodTargetCompareList.name}]] | 1 | EGFR-Ex20ins | |
| [[${prodTargetCompareList.name}]] | 1 | p300,IGF-1R,lipoxygenase | |
| [[${prodTargetCompareList.name}]] | 42 | FASN,EGFR,DNMT |
| Description |
Trastuzumab Emtansine(T-DM1,Ado-Trastuzumab emtansine) is an antibody-drug conjugate (ADC) that incorporates the HER2-targeted antitumor properties of trastuzumab with the cytotoxic activity of the microtubule-inhibitory agent DM1.Trastuzumab emtansine has a molecular weight of 145kDa.This product is supplied as 10mg/ml PBS solution.
|
|---|
| CAS No. | 1018448-65-1 |
|---|---|
| Molecular Weight | 145000 |
| DAR | 3.6 |
| ADC antiody | Trastuzumab |
| ADC cytotoxin | DM1 |
| Storage (From the date of receipt) |
Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles. |
*Literature analysis of various clone (for this target) products available on the market shows that Selleck's selected clones are more frequently applied. (data until September 2024)
Tel: +1-832-582-8158 Ext:3
If you have any other enquiries, please leave a message.